JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v10i7.15856ArticleFirst-line Treatment for Wound Healing of Tophi Ulceration in a Patient with Gout and Type 2 Diabetes: A Case Reporthttps://artdesignp.com/journal/JCNR/10/7/10.26689/jcnr.v10i7.15856XuNing,LinYadong,DongJiaqi,LiAimin20261072026-07-31Background: Tophi ulceration with infection and refractory wound healing remains a clinical challenge, particularly in patients with concurrent diabetes. Interleukin-1β (IL-1β) is a central mediator of gouty inflammation; targeted IL-1 inhibition may rapidly suppress inflammation and facilitate tissue repair. Case Presentation: This study reported the case of a 27-year-old male with a 6-year history of gouty arthritis, multiple tophi, infected left foot ulceration, and type 2 diabetes. Despite conventional anti-infective therapy, glycemic control, and local wound care, the ulcer showed limited improvement. Following a single subcutaneous injection of firsekibart (200 mg), wound exudate decreased rapidly, granulation tissue developed satisfactorily, and the ulcer healed progressively. At the 4-month follow-up, complete wound closure was achieved without recurrence or adverse events. Conclusion: Firsekibart demonstrated favorable anti-inflammatory and wound-healing effects in a patient with tophi ulceration complicated by diabetes, suggesting its potential as a therapeutic option for refractory cases. Prospective studies are warranted to confirm these findings.

Xiao L, Huang C, Chen W, et al., 2026, Expert Consensus on Surgical Management of Gouty Arthritis/Tophi. Chinese Journal of Traditional Medical Traumatology & Orthopedics, 34(2): 1–11.

Chazova I, Zhernakova Y, Kisliak O, et al., 2019, Consensus on Patients with Hyperuricemia and High Cardiovascular Risk Treatment. Systemic Hypertension, 16(4): 8–21.

Jiang J, Zhang T, Liu Y, et al., 2023, Prevalence of Diabetes in Patients with Hyperuricemia and Gout: A Systematic Review and Meta-analysis. Current Diabetes Reports, 23(6): 103–117.

Pan A, Teng G, Yuan J, et al., 2016, Bidirectional Association Between Diabetes and Gout: The Singapore Chinese Health Study. Scientific Reports, 6: 25766.

Chinese Burn Association, Yangtze River Delta Integrated Diabetic Foot Alliance, 2025, Practical Guideline on the Prevention and Management of Diabetic Foot in China (I). Chinese Journal of Burns and Wounds, 41(11): 1029–1049.

Kim Y, Lee H, Ryu J, et al., 2018, Sarcopenia Increases the Risk for Mortality in Patients Who Undergo Amputation for Diabetic Foot. Journal of Foot and Ankle Research, 11: 32.

Narang R, Dalbeth N, 2020, Pathophysiology of Gout. Seminars in Nephrology, 40(6): 550–563.

Erna R, Kartasasmita A, Boesoirie S, et al., 2025, Role of PPARγ, IL-1β Blockers, and TGF-β1 in Diabetic Wound Healing. Journal of Wound Management and Research,21(2): 58–66.

Xue Y, Chu T, Hu J, et al., 2025, Firsekibart Versus Compound Betamethasone in Acute Gout Patients: A Randomized Phase 3 Trial. Innovation (Camb), 6(8): 101015.

Dalbeth N, Gosling A, Gaffo A, et al., 2021, Gout. Lancet, 397(10287): 1843–1855.

Yoo J, 2025, Gouty Tophus Mimicking Calcific Tendinitis of the Supraspinatus: A Case Report. Journal of Orthopaedic Science Research, 6(3):1–5.

Lai B, Pang Z, 2022, Sepsis Complicated with Secondary Hemophagocytic Syndrome Induced by Giant Gouty Tophi Rupture. World Journal of Clinical Cases, 10(23): 8224–8231.

Chinese Diabetes Society, 2025, Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes Mellitus (2024 Edition). Chinese Journal of Diabetes Mellitus, 17(1): 16–139.

Mayrovitz H, Aoki K, 2025, Microcirculation in Wound Healing. In: Tuma R, et al., Handbook of Microcirculation. Springer.

Mirza R, Fang M, Ennis W, et al., 2013, Blocking Interleukin-1β Induces a Healing-Associated Wound Macrophage Phenotype and Improves Healing in Type 2 Diabetes. Diabetes, 62(7): 2579–2587.

Dai J, Shen J, Chai Y, et al., 2021, IL-1β Impaired Diabetic Wound Healing by Regulating MMP-2 and MMP-9 Through the p38 Pathway. Mediators of Inflammation, 2021: 6645766.

Yan C, Gao N, Sun H, et al., 2016, Targeting Imbalance Between IL-1β and IL-1 Receptor Antagonist Ameliorates Delayed Epithelium Wound Healing in Diabetic Mouse Corneas. American Journal of Pathology, 186(6): 1466–1480.